Molecular Diagnosis & Therapy

Papers
(The H4-Index of Molecular Diagnosis & Therapy is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
ADORA3: A Key Player in the Pathogenesis of Intracranial Aneurysms and a Potential Diagnostic Biomarker119
Predictive Ability of Serum Amino Acid Levels to Differentiate Fibromyalgia Patients from Healthy Subjects77
Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors69
Clinical Exome Reanalysis: Current Practice and Beyond53
Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target52
Molecular Therapy for Choroideremia: Pre-clinical and Clinical Progress to Date47
Comment on “Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta‑Analysis”46
A Window of Opportunity for Newborn Screening45
Prognostic Biomarker-Based Identification of Drugs for Managing the Treatment of Endometrial Cancer40
Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate40
Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors37
Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights36
Piflufolastat F 18: Diagnostic First Approval33
FAPI-Targeted Molecular Imaging: Transforming Insights into Post-Ischemic Myocardial Remodeling?31
Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk30
Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach29
Inflammatory Gene Panel Guiding the Study of Genetics in Inflammatory Bowel Disease29
Personalizing Oncolytic Immunovirotherapy Approaches27
Afamitresgene Autoleucel: First Approval26
Advances and Challenges in the Diagnosis of Leishmaniasis23
Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics23
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders22
0.073110103607178